Efficacy and tolerability of risperdal in schizophreniac
- Author:
Tan Ngoc Ngo
- Publication Type:Journal Article
- Keywords:
schizophrenia
- MeSH:
Risperidone;
Schizophrenia
- From:Journal of Practical Medicine
2002;435(11):27-30
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
21 patients with chronic schizopherenia (male: 15) with ages of 17-58 treated by Risperdal at dose of 3.96 mg/day within 8 weeks has shown that scores of PANSS scale, possitive scale and general scale were statistical significantly reduced (P< 0.001), score of negative scale was statistical significantly reduced (P < 0.001). The drug had a good tolerability (83.9% patients). The side-effects and complications including extrapyramidal syndrome were mild and not frequent. The efficacy was 80.6%.
